Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Venetoclax + Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Chicago, Illinois
This trial is testing a new combination therapy to treat people with a certain type of leukemia that has relapsed or is resistant to treatment. The goal is to find the best dose of the new combination therapy that doesn't cause severe side effects. The trial will also measure how well the new combination therapy works.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service